Tin-related defects and cation disorder are critical factors that limit the performance of Cu 2 ZnSn(S,Se) 4 (CZTSSe) thin-film solar cells (TFSCs) Partial substitution of Sn with Ge has been identified as an effective approach to suppressing antisite defects and reducing open-circuit voltage deficit ( V OC,def ). However, high-concentration Ge doping can have adverse effects on device performance. In this study, we employed an environmentally friendly n-butylammonium butyrate–based solution method to optimize the CZTSSe absorber layers and the resulting solar cells by introducing low-concentration Ge doping, where the atomic ratio of Ge/(Ge+Sn) was varied from 0 to 0.2. The crystal structure, surface morphology, roughness, and elemental chemical states of the films were systematically characterized by using X-ray diffractometer (XRD), scanning electron microscope (SEM), atomic force microscope (AFM), and X-ray photoelectron spectroscopy (XPS). Defect state distribution and carrier recombination mechanisms were further investigated using Raman spectroscopy, temperature-dependent admittance spectroscopy (T-AS), and temperature-dependent open-circuit voltage measurements. The optoelectronic performance of the devices was comprehensively evaluated through J – V measurements, electrical impedance spectroscopy (EIS), and external quantum efficiency (EQE) tests. The results demonstrated that low-concentration Ge doping effectively promotes the growth of large-grain layer, reduces surface roughness, widens the bandgap, and significantly suppresses [2Cu Zn + Sn Zn ] defect clusters and band-tail states, thereby reducing non-radiative recombination losses in both the bulk and at the interfaces. These synergistic improvements collectively enhance the carrier lifetime (τ EIS ), open-circuit voltage ( V OC ), short-circuit current density ( J SC ), and fill factor (FF). The optimal device, with a Ge doping ratio of 15%, achieved a maximum power conversion efficiency (PCE) of 8.65%. This work confirms that low-concentration Ge doping is an effective strategy for enhancing the performance of CZTSSe solar cells and provides important experimental insights into defect control.
No takes yet. Share an insight, caveat, or question.
Lv et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: